<DOC>
	<DOCNO>NCT00010387</DOCNO>
	<brief_summary>OBJECTIVES : I . Determine response rate 1-year event-free survival patient severe autoimmune hematologic disease treat high-dose cyclophosphamide .</brief_summary>
	<brief_title>Phase II Study High-Dose Cyclophosphamide Patients With Severe Autoimmune Hematologic Disease</brief_title>
	<detailed_description>PROTOCOL OUTLINE : Patients receive high-dose cyclophosphamide IV day 1-4 filgrastim ( G-CSF ) start day 10 continue blood count recover . Patients follow 1 , 3 , 6 , 12 month annually thereafter .</detailed_description>
	<mesh_term>Autoimmune Diseases</mesh_term>
	<mesh_term>Purpura</mesh_term>
	<mesh_term>Hemolysis</mesh_term>
	<mesh_term>Purpura , Thrombocytopenic</mesh_term>
	<mesh_term>Anemia , Hemolytic</mesh_term>
	<mesh_term>Anemia , Hemolytic , Autoimmune</mesh_term>
	<mesh_term>Felty Syndrome</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Diagnosis severe autoimmune hematologic disease Autoimmune hemolytic anemia OR Immune thrombocytopenia Failure least 2 standard treatment approach ( e.g. , prednisone therapy , splenectomy , intravenous immunoglobulin , immunosuppressant ) Inability taper prednisone dose le 10 mg/day OR Autoimmune neutropenia include follow : Felty 's syndrome OR Disorders large granular lymphocyte recurrent infection absolute neutrophil count le 200/mm3 Prior/Concurrent Therapy See Disease Characteristics Patient Characteristics Age : Not specify Performance status : Not specify Hematopoietic : See Disease Characteristics Hepatic : Not specify Renal : Creatinine great 2.5 mg/dL Cardiovascular : Ejection fraction least 40 % Pulmonary : FVC , FEV1 , DLCO least 50 % predict Other : Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception Not preterminal moribund</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>Felty syndrome</keyword>
	<keyword>autoimmune hemolytic anemia</keyword>
	<keyword>autoimmune neutropenia</keyword>
	<keyword>hematologic disorder</keyword>
	<keyword>immune thrombocytopenic purpura</keyword>
	<keyword>rare disease</keyword>
</DOC>